Nasser A - Search Results

1

Once-Daily SPN-812 200 and 400 mg in the treatment of ADHD in School-aged Children: A Phase III Randomized, Controlled Trial.

Nasser A, Liranso T, Adewole T, Fry N, Hull JT, Chowdhry F, Busse GD, Melyan Z, Cutler AJ, Findling RL, Schwabe S. Nasser A, et al. Clin Ther. 2021 Apr;43(4):684-700. doi: 10.1016/j.clinthera.2021.01.027. Epub 2021 Mar 6. Clin Ther. 2021. PMID: 33750646 Free article. Clinical Trial.

2

Efficacy, Safety, and Tolerability of RBP-7000 Once-Monthly Risperidone for the Treatment of Acute Schizophrenia: An 8-Week, Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 3 Study.

Nasser AF, Henderson DC, Fava M, Fudala PJ, Twumasi-Ankrah P, Kouassi A, Heidbreder C. Nasser AF, et al. J Clin Psychopharmacol. 2016 Apr;36(2):130-40. doi: 10.1097/JCP.0000000000000479. J Clin Psychopharmacol. 2016. PMID: 26862829 Clinical Trial.

3

A proposed anti-maladaptive aggression agent classification: improving our approach to treating impulsive aggression.

Robb AS, Schwabe S, Ceresoli-Borroni G, Nasser A, Yu C, Marcus R, Candler SA, Findling RL. Robb AS, et al. Among authors: nasser a. Postgrad Med. 2019 Mar;131(2):129-137. doi: 10.1080/00325481.2019.1574401. Epub 2019 Feb 14. Postgrad Med. 2019. PMID: 30678534 Review.

4

A Phase II Double-Blind, Placebo-Controlled, Efficacy and Safety Study of SPN-812 (Extended-Release Viloxazine) in Children With ADHD.

Johnson JK, Liranso T, Saylor K, Tulloch G, Adewole T, Schwabe S, Nasser A, Findling RL, Newcorn JH. Johnson JK, et al. Among authors: nasser a. J Atten Disord. 2020 Jan;24(2):348-358. doi: 10.1177/1087054719836159. Epub 2019 Mar 29. J Atten Disord. 2020. PMID: 30924702 Free PMC article. Clinical Trial.

5

Application of the Impulsive Aggression Diary in Adolescents with Attention-Deficit/Hyperactivity Disorder.

Ceresoli-Borroni G, Liranso T, Brittain ST, Connor DF, Evans CJ, Findling RL, Hwang S, Fry N, Candler SA, Robb AS, Saylor KE, Nasser A, Schwabe S. Ceresoli-Borroni G, et al. Among authors: nasser a. J Child Adolesc Psychopharmacol. 2019 Oct;29(8):599-607. doi: 10.1089/cap.2018.0089. Epub 2019 Jul 25. J Child Adolesc Psychopharmacol. 2019. PMID: 31343272

6

A Novel Assessment Tool for Impulsive Aggression in Children with Attention-Deficit/Hyperactivity Disorder.

Ceresoli-Borroni G, Liranso T, Brittain ST, Connor DF, Evans CJ, Findling RL, Hwang S, Candler SA, Robb AS, Nasser A, Schwabe S. Ceresoli-Borroni G, et al. Among authors: nasser a. J Child Adolesc Psychopharmacol. 2019 Oct;29(8):592-598. doi: 10.1089/cap.2019.0035. Epub 2019 Aug 2. J Child Adolesc Psychopharmacol. 2019. PMID: 31369291 Free PMC article.

7

Closing the gap: unmet needs of individuals with impulsive aggressive behavior observed in children and adolescents.

Robb AS, Connor DF, Amann BH, Vitiello B, Nasser A, O'Neal W, Schwabe S, Ceresoli-Borroni G, Newcorn JH, Candler SA, Buitelaar JK, Findling RL. Robb AS, et al. Among authors: nasser a. CNS Spectr. 2021 Oct;26(5):448-456. doi: 10.1017/S1092852920001224. Epub 2020 Mar 31. CNS Spectr. 2021. PMID: 32228725 Review.

8

A Double-Blind, Randomized Study of Extended-Release Molindone for Impulsive Aggression in ADHD.

Ceresoli-Borroni G, Nasser A, Adewole T, Liranso T, Xu J, Schwabe S, Findling RL. Ceresoli-Borroni G, et al. Among authors: nasser a. J Atten Disord. 2021 Sep;25(11):1564-1577. doi: 10.1177/1087054720909084. Epub 2020 Apr 26. J Atten Disord. 2021. PMID: 32338106 Clinical Trial.

9

A Phase III, Randomized, Placebo-controlled Trial to Assess the Efficacy and Safety of Once-daily SPN-812 (Viloxazine Extended-release) in the Treatment of Attention-deficit/Hyperactivity Disorder in School-age Children.

Nasser A, Liranso T, Adewole T, Fry N, Hull JT, Chowdhry F, Busse GD, Cutler AJ, Jones NJ, Findling RL, Schwabe S. Nasser A, et al. Clin Ther. 2020 Aug;42(8):1452-1466. doi: 10.1016/j.clinthera.2020.05.021. Epub 2020 Jul 25. Clin Ther. 2020. PMID: 32723670 Free article. Clinical Trial.

10

Evaluation of the Effect of SPN-812 (Viloxazine Extended-Release) on QTc Interval in Healthy Adults.

Nasser A, Faison SL, Liranso T, Adewole T, Busse GD, Fava M, Kleiman RB, Schwabe S. Nasser A, et al. J Clin Psychiatry. 2020 Oct 13;81(6):20m13395. doi: 10.4088/JCP.20m13395. J Clin Psychiatry. 2020. PMID: 33049804 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

461 results

Search Page